Prolonged coronary artery occlusion-reperfusion sequences reduce myocardial free radical production: An electron paramagnetic resonance study

American Heart Journal

Volumn 132, Issue 6, 1996, Pages 1147-1155

  Lindower, Paul D ^a   Spencer, Kirk T ^a   Caterine, Matthew R ^a   Sharma, Mukesh K ^a   Buettner, Garry R ^a   Kerber, Richard E ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; FREE RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; ELECTRON SPIN RESONANCE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0030464969     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90457-3     Document Type: Article

References (50)

1. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975;56:978-85.
2. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
3. Kloner RA, Przyklenk K, Patel B. Altered myocardial states: the stunned and hibernating myocardium. Am J Med 1989;(Suppl 1A):14-22.
4. Bolli R. Mechanism of myocardial stunning. Circulation 1990;82:723-38.
5. Sharma MK, Buettner GR, Spencer KT, Kerber RE. Ascorbyl free radical as a real-time marker of free radical generation in briefly ischemic and reperfused hearts: an electron paramagnetic resonance study. Circ Res 1994;74:650-8.
6. Buettner GR, Jurkiewicz BA. Ascorbate free radical as a marker of oxidative stress: an EPR study. Free Radical Biol Med 1993;14:49-55.
7. Buettner GR, Kiminyo KP. Optimal EPR detection of weak nitroxide spin adduct and ascorbyl free radical signals. J Biochem Biophys Methods 1992;24:147-51.
8. Jennings RB, Reimer KA. Factors involved in salvaging ischemic myocardium: effects of reperfusion of arterial blood. Circulation 1983;68(Suppl I):I-25-36.
9. Kramer JH, Arroyo CM, Dickens BF, Weglicki WB. Spin-trapping evidence that graded myocardial ischemia alters post-ischemic superoxide production. Free Radical Biol Med 1987;3:153-9.
10. Takemura G, Onodera T, Ashraf M. Quantification of hydroxyl radical and its lack of relevance to myocardial injury dury early reperfusion after graded ischemia in rat hearts. Circ Res 1992;71:96-105.
11. Henry TD, Archer SL, Nelson D, Weir EK, From AHL. Postischemic oxygen radical production varies with duration of ischemia. Am J Physiol 1993;264:H1478-84.
12. Arroyo CM, Kramer JH, Leiboff RH, Mergner GW, Dickens BF, Weglicki WB. Spin trapping of oxygen and carbon-centered free radicals in ischemic canine myocardium. Free Radical Biol Med 1987;3:313-6.
13. Mergner GW, Weglicki WB, Kramer JH. Postischemic free radical production in the venous blood of the regionally ischemic swine heart: effect of deferoxamine. Circulation 1991;84:2079-90.
14. Jolly SR, Kane WJ, Bailie MB, Abrams GD, Lucehesi BR. Canine myocardial reperfusion injury: its reduction by the combined administration of Superoxide dismutase and catalase. Circ Res 1984;54:277-85.
15. Myers ML, Bolli R, Lekich RF, Hartley CJ, Roberts R. Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia. Circulation 1985;72:915-21.
16. Werns SW, Shea MJ, Driscoll EM, Cohen C, Abrams GD, Pitt B, et al. The independent effects of oxygen radical scavengers on canine infarct size: reduction by Superoxide dismutase but not catalase. Circ Res 1985;56:895-8.
17. Gross GJ, Farber NE, Hardman HF, Warltier DC. Beneficial actions of Superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol 1986;250:H372-7.
18. Ambrosio G, Becker LC, Hutchins GM, Weisman HF, Weisfeldt ML. Reduction in experimental infarct size by recombinant human super-oxide dismutase: insights into the pathophysiology of reperfusion injury. Circulation 1986;74:1424-33.
19. Przyklenk K, Kloner RA. Superoxide dismutase plus catalase improve contractile function in the canine model of the "stunned myocardium." Circ Res 1986;58:148-56.
20. Werns SW, Simpson PJ, Mickelson JK, Shea MJ, Pitt B, Lucchesi BR. Sustained limitation by Superoxide dismutase of canine myocardial injury due to regional ischemia followed by reperfusion. J Cardiovasc Pharmacol 1988;11:36-44.
21. Tamura Y, Chi L, Driscoll EM, Hoff PT, Freeman BA, Gallagher KP, et al. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart. Circ Res 1988;63:944-59.
22. Gallagher KP, Buda AJ, Pace D, Gerren RA, Shlafer M. Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion. Circulation 1986;73:1065-76.
23. Przyklenk K, Kloner RA. "Reperfusion injury" by oxygen-derived free radicals? Effect of Superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res 1989;64:86-96.
24. Uraizee A, Reimer KA, Murry CE, Jennings RB. Failure of Superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation 1987;75:1237-48.
25. Richard VJ, Murry CE, Jennings RB, Reimer KA. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs. Circulation 1988;78:473-80.
26. Nejima J, Knight DR, Fallon JT, Uemura N, Manders T, Canfield DR, et al. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs. Circulation 1989;79:143-53.
27. Chi L, Tamura Y, Hoff PT, Macha M, Gallagher KP, Schork MA, et al. Effect of Superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage. Circ Res 1989;64:665-75.
28. Romson JL, Hook BG, Rigot VH, Schork MA, Swanson DP, Lucchesi BR. The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction. Circulation 1982;66:1002-11.
29. Jolly SR, Kane WJ, Hook BG, Abrams GD, Kunkel SL, Lucchesi BR. Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. Am Heart J 1986;112:682-90.
30. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Luccesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983;67:1016-23.
31. Mullane KM, Read N, Salmon JA, Moncada S. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther 1984;228:510-22.
32. Jolly SR, Lucchesi BR. Effect of BW755C in an occlusion-reperfusion model of ischemic myocardial injury. Am Heart J 1983;106:8-13.
33. Simpson PJ, Mitsos SE, Ventura A, Gallagher KP, Fontone JC, Abrams GH, et al. Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J 1987;113:129-37.
34. Engler R, Covell JW. Granulocytes cause reperfusion ventricular dysfunction after 15 minute ischemia in the dog. Circ Res 1987;61:20-8.
35. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia: evidence for neutrophil mediated reperfusion injury. Circulation 1989;80:1816-27.
36. Simpson PJ, Fantone JC, Mickelson JK, Gallagher KP, Lucchesi BR. Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion. Circ Res 1988;63:1070-9.
37. Chambers DE, Parks DA, Patterson G, Roy R, McCord JM, Yoshida S, et al. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 1985;17:145-52.
38. Werns SW, Shea MJ, Mitsos SE, Dysko RC, Fantone JC, Schork MA, et al. Reduction of the size of infarction by allopurinol in ischemic-reperfused canine heart. Circulation 1986;73:518-24.
39. Charlat ML, O'Neill PG, Egan JM, Abernethy DR, Michael LH, Myers ML, et al. Evidence for a pathogenetic role of xanthine oxidase in the "stunned" myocardium. Am J Physiol 1987;252:H566-77.
40. Puett DW, Forman MB, Cates CU, Wilson BH, Hande KR, Friesinger GC, et al. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion. Circulation 1987;76:678-86.
41. Reimer KA, Jennings RB. Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs. Circulation 1985;71:1069-75.
42. Engler R, Gilpin E. Can Superoxide dismutase alter myocardial infarct size? Circulation 1989;79:1137-42.
43. Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion: resolved and unresolved issues. Circulation 1989;80:1115-27.
44. Lucchesi BR. Myocardial ischemia, reperfusion, and free radical injury. Am J Cardiol 1990;65:141-231.
45. Naslund U, Haggmark S, Johansson G, Marklund SL, Reitz S. Limitation of myocardial infarct size by Superoxide dismutase as an adjunct to reperfusion after different durations of coronary occlusion in the pig. Circ Res 1990;66:1294-301.
46. Caterine MR, Spencer KT, Sharma MK, Beuttner GR, Kerber RE. Direct current shocks cause free radical generation [abstract]. Circulation 1994;90:I-5.
47. Reimer KA, Jennings RB, Cobb FR, Murdock RH, Greenfield JC, Becker LC, et al. Animal models for protecting human myocardium: results of the NHLBI Cooperative Study - comparison of unconscious and conscious dog models. Circ Res 1985;56:651-65.
48. Edens RE, Lindhardt RJ, Bell CS, Weiler JM. Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum. Immunopharmacology 1994;27:145-53.
49. Edens RE, Lindhardt RJ, Weiler JM. Heparin is not just an anticoagulant anymore: six and one half decades of studies on the ability of heparin to regulate complement activity. Complement Profiles 1993;1:96-120.
50. Weisman HF, Bartow TB, Leppo MK, Marsh HC, Carson GR, Concino MF, et al. Soluble human complement receptor type I: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990;249:146-51.